|
| Exchange Disseminated Time 30/05/2016 22:07:52 | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has transacted the following:
1. Recommended payment of dividend of Re. 1/- (Rupee One Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2016, subject to the approval of the members at the ensuing Annual General Meeting of the Company.
The dividend will be paid on or about last week of September, 2016.
2. Approved the request(s) received from the promoter group entities mentioned below for reclassifying themselves as “public” as permitted under Regulation 31A of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 subject to the approval of shareholders, stock exchanges, and other regulatory authorities, if any:
1. Mr. Jayant S Sanghvi
2. Mr. Ajay Valia
3. Mr. Jitendra Valia
4. Mr. Jitendra Valia HUF
5. Mr. Kirit Valia
6. Mr. Kirit Valia HUF
7. Pratham Investments
8. Mrs. Varsha Doshi
9. Mrs. Dipti Modi
3. Decided to hold the Meeting of the Board of Directors on June 23, 2016 for evaluating a proposal of Buy Back of Equity Shares of the Company.
Further, window closure for trading by designated persons as per Insider Trading Rules of the Company will be from June 14, 2016 to June 27, 2016 (both days inclusive), pursuant to evaluation of the proposal of Buy Back of Equity Shares of the Company.
The meeting of the Board of Directors commenced on May 30, 2016 at 4:00 p.m. and concluded at 9:35 p.m. |
|
|